← back to search

Fucheng Zhou

Harbin Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, and RNA modifications and cancer.
h-index
9
citations
290
works
19
NIH funding
primary concept
email

Recent publications

RUNX1 promotes NSCLC progression by ACP5/SMAD3-mediated M2 macrophage polarization
Inflammation Research 2025cited by 2position: middledoi
Identification and prediction of biomarkers, immune infiltration features, molecular regulatory mechanisms, and potential therapeutic agents associated with cuproptosis in osteoarthritic cartilage
Research Square 2024cited by 0position: middledoi
Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer
Frontiers in Cellular and Infection Microbiology 2023cited by 45position: middledoi
Sevoflurane Attenuates Proliferative and Migratory Activity of Lung Cancer Cells via Mediating the MicroRNA-100-3p/Sterol O-Acyltransferase 1 Axis
The Chinese Journal of Physiology 2023cited by 4position: middledoi
A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
Frontiers in Genetics 2022cited by 11position: middledoi
Knockdown of LINC00511 decreased cisplatin resistance in non-small cell lung cancer by elevating miR-625 level to suppress the expression of leucine rich repeat containing eight volume-regulated anion channel subunit E
Human & Experimental Toxicology 2022cited by 8position: middledoi
Proliferation, apoptosis and invasion of human lung cancer cells are associated with NFATc1
Experimental and Therapeutic Medicine 2022cited by 2position: middledoi
PIGF and Flt-1 on the surface of macrophages induces the production of TGF-β1 by polarized tumor-associated macrophages to promote lung cancer angiogenesis
European Journal of Pharmacology 2021cited by 26position: middledoi
CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
Frontiers in Oncology 2021cited by 21position: middledoi
Genipin Inhibits LPS-Induced Inflammatory Response in BV2 Microglial Cells
Neurochemical Research 2017cited by 43position: middledoi
Up-regulation of long non-coding HOTTIP functions as an oncogene by regulating HOXA13 in non-small cell lung cancer.
PubMed 2016cited by 57position: middle
MicroRNA-300 inhibited glioblastoma progression through ROCK1
Oncotarget 2016cited by 31position: firstdoi
Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB
Molecular Medicine Reports 2016cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qingsong Li · Dalian Ocean University4 papers (2016–2017)Zhen Hao · Harbin Medical University4 papers (2016–2017)Boxiong Ni · Harbin Medical University4 papers (2021–2025)Bicheng Fu · Harbin Medical University4 papers (2021–2025)Xuanxi Liu · Harbin Medical University4 papers (2016–2017)Shidong Xu · Harbin Medical University3 papers (2021–2023)Yongri Zheng · Harbin Medical University3 papers (2016–2017)Xianglong Kong · Harbin Medical University3 papers (2021–2023)Fenghai Ren · Harbin Medical University3 papers (2021–2022)Sainan Pang · Harbin Medical University3 papers (2021–2022)Junfeng Wang · South China Agricultural University2 papers (2021–2022)Junhui Chen · Guangzhou University of Chinese Medicine2 papers (2021–2025)Changjun He · Harbin Medical University2 papers (2021–2023)Jianlong Bu · Harbin Medical University2 papers (2021–2023)Fei Yuan · Harbin Medical University2 papers (2016–2016)Zuobin Liang · Harbin Medical University2 papers (2016–2017)Benkun Liu · Harbin Medical University2 papers (2021–2022)Kaibin Zhu · Harbin Medical University2 papers (2022–2022)Lantao Chen · Harbin Medical University2 papers (2022–2022)Jianjiao Wang · Hebei North University2 papers (2016–2017)